Skip to main content

Abstract

Ischemic heart disease (IHD) is considered more common in men than women and most of the initial studies in IHD conducted focused mainly on men. Often women were not included in cardiovascular research programs. The life-time risk of IHD is one in three for women [1], but women themselves consider breast cancer as their major killer rather than IHD [2]. Since the early 1990s some research has concentrated on IHD in women and a better understanding of gender-related differences has been developed; this includes the epidemiology of IHD in women, identifying risk factors, determining the diagnostic problems encountered with IHD, and possible treatment outcomes [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lloyd-Jones DM, Larson MG, Beiser A, Levy D (1999) Lifetime risk of developing coronary heart disease. Lancet 353:89–92.

    Article  PubMed  CAS  Google Scholar 

  2. Legato MJ, Padus E, Slaughter E (1997) Women’s perceptions of their general health, with special reference to their risk of coronary artery disease: results of a national telephone survey. J Womens Health 6:189–198.

    PubMed  CAS  Google Scholar 

  3. Kasper AS (2002) Understanding women’s health: an overview. Clin Obst Gynecol 45(4):1189–1197.

    Article  Google Scholar 

  4. Benjamin E J, Smith SC Jr, Cooper RS, Martha and Luepker RV (2002) Task Force #1—Magnitude of the prevention problem: opportunities and challenges. J Am Coll Cardiol 40(4):588–603.

    Article  PubMed  Google Scholar 

  5. Wenger NK, Speroff L, Packard B (1993) Cardiovascular health and disease in women. N Eng J Med 329(4):247–256.

    Article  CAS  Google Scholar 

  6. Murray CJL, Lopez AD (1996) The global burden of disease in 1990. In Murray CJL, Lopez AD, Harvard School of Public Health, World Health Organizations and World Bank, Editors, The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Disease, Injuries, and Risk Factors in 1990 and Projected to 2020, Harvard School of Public Health, Cambridge, MA, pp. 247–293.

    Google Scholar 

  7. Keys AB (1980) Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Harvard University Press, Cambridge, MA and London, England.

    Google Scholar 

  8. Kuulasmaa K, Tunstall-Pedoe H, Dobson A et al. (2000) Estimation of contribution of changes in classic risk factors to trends in coronary event rates across the WHO MONICA Project populations. Lancet 355:675–687.

    Article  PubMed  CAS  Google Scholar 

  9. The University of York (1996) Ethnicity and Health: review of literature and guidelines for purchasers in areas of cardiovascular disease, mental health and haemoglobinopathies. NHS Centre for Reviews and Dissemination Social Policy Research Unit. CDR report 5, January, pp. 5–7.

    Google Scholar 

  10. McGovern PG, Pankow JS, Shahar E et al. (1996) Recent trends in acute coronary heart disease – mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med 334:884–890.

    Article  PubMed  CAS  Google Scholar 

  11. Giovino GA, Schooley MW et al. (1994) Summer Surveillance for selected tobacco-use behaviors – United States, 1900–1994. Morbidity and Mortality Weekly Report of the Centre for Disease Control Surveillence Summary 43:1–43.

    CAS  Google Scholar 

  12. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, and Rifkind BM (1987) Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75:1102–1109.

    PubMed  CAS  Google Scholar 

  13. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Assoc 280:605–613.

    Article  CAS  Google Scholar 

  14. Stampfer MJ and Colditz GA (1991) Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20:47–63.

    Article  PubMed  CAS  Google Scholar 

  15. Mikkola TS, Clarkson TB (2002) Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 53:605–619.

    Article  PubMed  CAS  Google Scholar 

  16. Wackers FJTh, Young Lh, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE (2004) for the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects. The DIAD study. Diabetes Care 27:1954–1961.

    Article  PubMed  Google Scholar 

  17. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O’Reilly MG, Winters WL Jr, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC Jr (2002) American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 106:1883–1892.

    Article  PubMed  Google Scholar 

  18. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM (2003) SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003.

    Article  PubMed  CAS  Google Scholar 

  19. Lerner DJ, Kannel WB (1986) Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111:383–390.

    Article  PubMed  CAS  Google Scholar 

  20. Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG, Marwick TH, Mosca L, Patel AR, Quinones MA, Redberg RF, Taubert KA, Taylor AJ, Thomas GS, Wenger NK (2005) Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease. Consensus statement from the cardiac imaging Committee, Council on Clinical Cardiology, and the cardiovascular imaging and intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 111:682–696.

    Article  PubMed  Google Scholar 

  21. Kim C, Kwok YS, Heagerty P, Redberg R (2001) Pharmacologic stress testing for coronary artery disease: a meta-analysis. Am Heart J 142:934–944.

    Article  PubMed  CAS  Google Scholar 

  22. Ali Raza J, Reeves WC, Movahed A (2001) Pharmacologic stress agents for evaluation of ischemic heart disease. Int J Cardiol 81:157–67.

    Article  PubMed  CAS  Google Scholar 

  23. Arruda-Olson AM, Juracan EM, Mahoney DW, McCully RB, Roger VL, Pellika PA (2002) Prognostic value of exercise echocardiography in 5798 patients: Is there a gender difference? J Am Coll Cardiol 39:625–631.

    Article  PubMed  Google Scholar 

  24. Mieres JH, Shaw LJ, Hendel RC, Miller DD, Bonow RO, Berman DS, Heller GV, Mieres JH, Bairey-Merz CN, Berman DS, Bonow RO, Cacciabaudo JM, Heller GV, Hendel RC, Kiess MC, Miller DD, Polk DM, Shaw LJ, Smanio PE, Walsh MN (2003) Writing Group on Perfusion Imaging in Women. American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease – the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women. J Nucl Cardiol 10:95–101.

    Article  PubMed  Google Scholar 

  25. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O’Gara PT, Carabello BA, Russell RO Jr, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC Jr, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO (2003) American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American Society for Nuclear Cardiology. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 108:1404–1418.

    Article  PubMed  Google Scholar 

  26. Taillefer R, DePuey G, Udelson JE, Beller GA, Latour Y, Reeves F (1997) Comparative diagnostic accuracy of Tl-201 and Tc-99m Sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 29:69–77.

    Article  PubMed  CAS  Google Scholar 

  27. Amanullah AM, Berman DS, Hachamovitch R, Kiat H, Kang X, Friedman JD (1997) Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT. Am J Cardiol 80:132–137.

    Article  PubMed  CAS  Google Scholar 

  28. Friedman TD, Greene AC, Iskandrian AS, Hakki AH, Kane AS, Segal BL (1982) Exercise thallium 201 myocardial scintigraphy in women: correlation with coronary angiography. Am J Cardiol 49:1632–1637.

    Article  PubMed  CAS  Google Scholar 

  29. Hachamovitch R, Berman DS, Kiat H, Bairey CN, Cohen I, Cabico A, Friedman J, Germano G, Van Train KF, Diamond GA (1996) Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 28:34–44.

    Article  PubMed  CAS  Google Scholar 

  30. Berman DS, Kang X, Hayes SW, Friedman JD, Cohen I, Abidov A, Shaw LJ, Amanullah AM, Germano G, Hachamovitch R (2003) Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol l41:1125–1133.

    Article  Google Scholar 

  31. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, Borges-Neto S, Berman DS, Waters DD, Heller GV (2002) Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 105:32–40.

    Article  PubMed  Google Scholar 

  32. Sharir T, Kang X, Germano G, Bax JJ, Shaw LJ, Gransar H, Cohen I, Hayes SW, Friedman JD, Berman DS (2006) Prognostic value of poststress left ventricular volume and ejection fraction by gated myocardial perfusion SPECT in women and men: gender-related differences in normal limits and outcomes. J Nucl Cardiol 13:495–506.

    Article  PubMed  Google Scholar 

  33. Rasulova N, Singh A, Demetriadou O, Georgiou G, Yiannakkaras C, Khodjibekov M, Al-Nahhas A (2008) Clinical significance of myocardial perfusion abnormalities in patients with varying degree of coronary artery stenosis. Nucl Med Commun 29(2):129–136.

    Article  PubMed  Google Scholar 

  34. Johnson BD, Shaw LJ, Pepine CJ, Reis SE, Kelsey SF, Sopko G, Rogers WJ, Mankad S, Sharaf BL, Bittner V, Bairey Merz CN (2006) Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women’s Ischaemia Syndrome Evaluation (WISE) study Eur Heart J 27:1408–1415.

    Article  PubMed  Google Scholar 

  35. Shaw LJ, Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ (2008) Post-Menopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) Sponsored Women’s Ischemia Syndrome Evaluation (WISE). J Clin Endocrinol Metab 93:1276–1284.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Khan, A., Buscombe, J. (2009). Nuclear Cardiology in Women. In: Movahed, A., Gnanasegaran, G., Buscombe, J., Hall, M. (eds) Integrating Cardiology for Nuclear Medicine Physicians. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78674-0_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-78674-0_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-78673-3

  • Online ISBN: 978-3-540-78674-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics